TABLE 1.
Patient | Gender | Age when clinical sample obtained (yr) | Year of diagnosis | Country of birth | Epidemiological link with: | Comments |
---|---|---|---|---|---|---|
NL05-01 | M | 36 | 2005 | Somalia | ≥6 mo in the Netherlands | |
NL06-02 | M | 26 | 2006 | Somalia | <6 mo in the Netherlands; RFLP 276 | |
NL11-03 | M | 22 | 2011 | Eritrea | MDR | |
NL13-04 | F | 10 | 2013 | Somalia | MDR | |
NL14-05 | M | 25 | 2014 | Eritrea | NL14-06 | |
NL14-06 | M | 24 | 2014 | Eritrea | NL14-05 | |
NL15-07 | M | 23 | 2015 | Netherlands | ||
NL15-08 | F | 28 | 2015 | Somalia | <6 mo in the Netherlands | |
NL16-09 | M | 73 | 2016 | Somalia | NL16-10 | |
NL16-10 | F | 20 | 2016 | Somalia | NL16-09, NL16-11, NL16-12 | |
NL16-11 | M | 17 | 2016 | Somalia | NL16-10 | |
NL16-12 | F | 46 | 2016 | Somalia | NL16-10 | |
DK15-01 | M | 32 | 2015 | Unknown | ||
DK16-03 | M | 28 | 2016 | Eritrea | ||
DK15-04 | M | 27 | 2015 | Eritrea | ||
DK01-05 | F | 21 | 2001 | Somalia | MDR | |
DK16-06 | M | 22 | 2016 | Eritrea | ||
DK14-07 | M | 19 | 2014 | Somalia | Rifampin monoresistant | |
DK14-08 | F | 20 | 2014 | Somalia | ||
DK03-09 | M | 32 | 2003 | Somalia | ||
DK05-11 | M | 14 | 2005 | Somalia | ||
DK16-12 | M | 29 | 2016 | Eritrea | ||
DK06-14 | M | 6 | 2006 | Somalia | DK06-29 | |
DK06-15 | F | 43 | 2006 | Somalia | ||
DK07-16 | F | 27 | 2007 | Uganda | ||
DK07-17 | F | 17 | 2007 | Somalia | ||
DK05-18 | F | 30 | 2005 | Somalia | ||
DK05-19 | M | 21 | 2005 | Eritrea | ||
DK04-20 | M | 44 | 2004 | Somalia | ||
DK09-21 | F | 19 | 2009 | Somalia | ||
DK16-22 | F | 29 | 2016 | Eritrea | ||
DK15-23 | M | 27 | 2015 | Somalia | ||
DK16-24 | F | 20 | 2016 | Eritrea | ||
DK15-25 | M | 52 | 2015 | Denmark | ||
DK14-26 | M | 20 | 2014 | Denmark | Somalia-born parents | |
DK16-27 | F | 33 | 2016 | Eritrea | ||
DK06-29 | M | 42 | 2006 | Somalia | DK06-14 | |
DK06-30 | M | 20 | 2006 | Somalia | ||
DK13-31 | M | 28 | 2013 | Somalia | ||
DK15-32 | M | 30 | 2015 | Eritrea |